We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders

By LabMedica International staff writers
Posted on 27 Mar 2025

Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems. More...

By monitoring these molecules, scientists can gain valuable insights into disease onset, overall health, treatment responses, and the complex operations of biological systems. However, current metabolite sensing techniques have limitations. Most methods rely on resource-heavy lab tests that provide only brief snapshots from isolated samples, while the few continuous sensors available mainly focus on tracking blood sugar levels. Researchers may have now found a way to overcome these limitations.

An interdisciplinary team led by the California NanoSystems Institute at UCLA (CNSI, Los Angeles, CA, USA) has demonstrated a sensor technology based on natural biochemical processes, which can continuously and reliably measure a wide variety of metabolites simultaneously. The researchers see this technology as a complement to traditional lab methods like mass spectrometry, rather than a replacement. Scientists can still use mass spectrometers to identify compounds of interest and then utilize these sensors to monitor those compounds in real-time within living systems. These sensors are built onto electrodes made of tiny cylinders known as single-wall carbon nanotubes. These electrodes act like miniature biochemical laboratories, using enzymes and helper molecules called cofactors to perform reactions that replicate the body's metabolic processes. Depending on the target metabolite, the sensors either detect it directly or convert it into a detectable form via a series of enzymatic reactions. The detection works through enzymes that catalyze electron-exchanging reactions, generating an electrical current on the electrodes’ surface, which can be measured to determine metabolite levels.

Additionally, other enzymes in the system work to prevent false signals by neutralizing interfering molecules, similar to how enzymes in our bodies detoxify substances. Reflecting the ability to run multiple reactions both in sequence and parallel, the researchers have named this technology "tandem metabolic reaction-based sensors" (TMR sensors). Traditional enzymatic sensors typically support single-step reactions without cofactors, but by incorporating cofactors, TMR sensors can detect over 800 metabolites and cover more than two-thirds of the body’s metabolites with just one conversion step. In a series of experiments, the team showed that the technology could continuously and sensitively measure a set of 12 clinically important metabolites. They successfully measured metabolites in sweat and saliva from patients undergoing treatment for epilepsy and from individuals with conditions resembling diabetes complications. The study, published in Proceedings of the National Academy of Sciences, also revealed a gut bacteria-derived metabolite in the brain that could cause neurological disorders if it accumulates.

The ability of these sensors to track a broad range of metabolites across various biological settings presents exciting possibilities for advancing human health and scientific research. These sensors could transform the care of metabolic and cardiovascular diseases by enabling earlier and more precise diagnoses, as well as tailoring treatments to individual metabolic profiles. The technology could also optimize fitness and athletic performance by tracking how the body metabolizes energy under different conditions. In drug development, these sensors could provide real-time insights into how treatments influence metabolic pathways — from evaluating cancer therapies that inhibit tumor growth through enzyme inhibition to monitoring bacterial metabolite production for better-targeted antibiotics. With many potential applications, this technology also holds promise in exploring the gut-brain connection — a burgeoning area of biomedical research. The research team is now working to adapt their platform to address unresolved research questions and explore new diagnostic opportunities.

“Decades of research have mapped natural metabolic pathways linking metabolites to specific enzymatic reactions,” said senior corresponding author Sam Emaminejad, an associate professor of electrical and computer engineering at the UCLA Samueli School of Engineering and a CNSI member. “By adapting carefully selected enzymes and cofactors for different functions, our electrodes replicate these complex reactions, enabling reliable detection of a far broader set of metabolites than conventional sensors. The robustness comes from evolution itself — enzymes and cofactors, refined over tens of millions of years, are highly sensitive, specific, and stable. We’re harnessing nature’s own blueprint and molecular machinery to track the very biochemical processes they sustain.”

Related Links:
CNSI


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.